Literature DB >> 22085161

Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC).

Sangchul Lee1, Hwang Gyun Jeon, Cheol Kwak, Hyeon Hoe Kim, Seok-Soo Byun, Sang Eun Lee, Eunsik Lee.   

Abstract

UNLABELLED: There has been some controversy about the gender differences in survival in patients with RCC. Korean women with RCC had a lower proportion of clear cell histology and a higher proportion of chromophobe histology. This histological difference might have driven the better survival rates in Korean women.
OBJECTIVE: To assess whether there are gender-specific differences in the clinicopathological features and prognosis in a large cohort of Korean patients with renal cell carcinoma (RCC) compared with Western patients. PATIENTS AND METHODS: Medical records of 1616 patients clinically diagnosed with RCC who underwent partial or radical nephrectomy were analysed between January 1988 and July 2009. In all, 1508 patients diagnosed with RCC based on pathology reports were included for evaluation. The mean follow-up period was 73.1 months. The gender-specific differences in the clinicopathological features and survival rates were evaluated using the Kaplan-Meier method and Cox proportional hazards models.
RESULTS: Of the 1508 patients, 439 (29.1%) were women. Korean men had a higher proportion of clear cell histology (84.3% vs 72.0%, P < 0.001) and a lower percentage of chromophobe histology (5.2% vs 12.5%, P < 0.001) than Korean women. There were no gender-specific differences in pathological T stage, positive lymph nodes or distant metastases, or Fuhrman's nuclear grade (P > 0.05). For both cancer-specific and overall survival, Kaplan-Meier curves showed that women had a better survival rate than men (P = 0.039 and P = 0.015, respectively).
CONCLUSIONS: Korean women with RCC had significantly better survival rates than Korean men. Additionally, Korean women with RCC had a lower proportion of clear cell histology and a higher proportion of chromophobe histology. This histological difference might have driven the better survival rates in Korean women.
© 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 22085161     DOI: 10.1111/j.1464-410X.2011.10667.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  12 in total

1.  Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment.

Authors:  Noriyuki Ito; Shinsuke Kojima; Satoshi Teramukai; Yoshiki Mikami; Osamu Ogawa; Tomomi Kamba
Journal:  Int J Clin Oncol       Date:  2015-05-16       Impact factor: 3.402

2.  Expression of angiogenic factors is increased in metastasised renal cell carcinomas.

Authors:  Mahmoud Abbas; Johannes Salem; Angelika Stucki-Koch; Mareike Rickmann; Viktor Grünwald; Thomas Herrmann; Danny Jonigk; Hans Kreipe; Kais Hussein
Journal:  Virchows Arch       Date:  2014-01-14       Impact factor: 4.064

3.  Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.

Authors:  Matthias May; Atiqullah Aziz; Richard Zigeuner; Thomas Chromecki; Luca Cindolo; Luigi Schips; Ottavio De Cobelli; Bernardo Rocco; Cosimo De Nunzio; Andrea Tubaro; Ioman Coman; Michael Truss; Orietta Dalpiaz; Bernd Hoschke; Christian Gilfrich; Bogdan Feciche; Anette Stoltze; Fabian Fenske; Hans-Martin Fritsche; Robert S Figenshau; Kerry Madison; Manuel Sánchez-Chapado; Maria Del Carmen Santiago Martin; Luigi Salzano; Giuseppe Lotrecchiano; Steven Joniau; Raphaela Waidelich; Christian Stief; Sabine Brookman-May
Journal:  World J Urol       Date:  2013-04-09       Impact factor: 4.226

Review 4.  Is gender becoming relevant in uro-oncological research? A bibliographical analysis.

Authors:  Frank Kunath; Bastian Keck; Simone Bertz; Sabine Brookman-May; Matthias May; Daniel Vergho; Arndt Hartmann; Hubertus Riedmiller; Bernd Wullich; Maximilian Burger
Journal:  World J Urol       Date:  2013-04-09       Impact factor: 4.226

5.  Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.

Authors:  Hiten D Patel; Max Kates; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Urol Oncol       Date:  2014-03-12       Impact factor: 3.498

6.  The impact of immunohistochemical expression of nitric oxide synthases on clinical and pathological features of renal cell carcinoma.

Authors:  Stênio de Cássio Zequi; José Humberto G T Fregnani; Ricardo L Favaretto; Walter H Costa; Rodrigo S Madeira Campos; Francisco P Fonseca; Gustavo C Guimaraes; Fernando A Soares; Isabela W da Cunha; Ademar Lopes
Journal:  World J Urol       Date:  2012-05-06       Impact factor: 4.226

7.  Increased risk of end-stage renal disease in patients with renal cell carcinoma: a 12-year nationwide follow-up study.

Authors:  Peir-Haur Hung; Hung-Bin Tsai; Kuan-Yu Hung; Chih-Hsin Muo; Mu-Chi Chung; Chao-Hsiang Chang; Chi-Jung Chung
Journal:  Medicine (Baltimore)       Date:  2014-08       Impact factor: 1.889

8.  Age-dependent association between sex and renal cell carcinoma mortality: a population-based analysis.

Authors:  Yuanyuan Qu; Haitao Chen; Weijie Gu; Chengyuan Gu; Hailiang Zhang; Jianfeng Xu; Yao Zhu; Dingwei Ye
Journal:  Sci Rep       Date:  2015-03-17       Impact factor: 4.379

9.  Clinical effectiveness of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography in management of renal cell carcinoma: a single institution experience.

Authors:  Aung Zaw Win; Carina Mari Aparici
Journal:  World J Nucl Med       Date:  2015 Jan-Apr

10.  Omental Nodular Deposits of Recurrent Chromophobe Renal Cell Carcinoma Seen on FDG-PET/CT.

Authors:  Aung Zaw Win; Carina Mari Aparici
Journal:  J Clin Imaging Sci       Date:  2014-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.